OHSU
Return to Listing

1 result(s) for VS-6063

PI Name Protocol # Title
Jeremy Cetnar IRB00010028 Phase 2 Study of VS-6063, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with KRAS Mutant Non-Small Cell Lung Cancer
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program